Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,359 | 111 | 87.4% |
| Travel and Lodging | $483.87 | 2 | 12.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $2,320 | 64 | $0 (2024) |
| Pacira Pharmaceuticals Incorporated | $661.86 | 5 | $0 (2024) |
| SI-BONE, INC. | $151.39 | 8 | $0 (2023) |
| Assertio Therapeutics, Inc. | $147.37 | 9 | $0 (2020) |
| Medtronic USA, Inc. | $88.01 | 1 | $0 (2017) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $71.96 | 4 | $0 (2023) |
| Forte Bio-Pharma LLC | $71.03 | 2 | $0 (2020) |
| PFIZER INC. | $65.81 | 5 | $0 (2019) |
| Sentynl Therapeutics, Inc. | $52.79 | 3 | $0 (2018) |
| Averitas Pharma Inc. | $42.84 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $902.69 | 12 | Pacira Pharmaceuticals Incorporated ($661.86) |
| 2023 | $599.51 | 17 | Boston Scientific Corporation ($497.53) |
| 2022 | $297.27 | 9 | Boston Scientific Corporation ($266.27) |
| 2021 | $620.49 | 15 | BOSTON SCIENTIFIC CORPORATION ($586.93) |
| 2020 | $97.95 | 5 | Boston Scientific Corporation ($63.64) |
| 2019 | $378.64 | 17 | Boston Scientific Corporation ($188.15) |
| 2018 | $435.68 | 22 | BOSTON SCIENTIFIC CORPORATION ($222.56) |
| 2017 | $510.42 | 16 | BOSTON SCIENTIFIC CORPORATION ($296.60) |
All Payment Transactions
113 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $116.98 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/23/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: General - Pain Management_NMD | ||||||
| 10/23/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/09/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: General - Pain Management_NMD | ||||||
| 08/28/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/15/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 05/28/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: General - Pain Management_NMD | ||||||
| 03/07/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Travel and Lodging | Cash or cash equivalent | $258.00 | General |
| Category: Pain Management | ||||||
| 03/07/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Travel and Lodging | Cash or cash equivalent | $225.87 | General |
| Category: Pain Management | ||||||
| 02/03/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $42.92 | General |
| Category: Pain Management | ||||||
| 02/03/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $9.29 | General |
| Category: Pain Management | ||||||
| 02/02/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $125.78 | General |
| Category: Pain Management | ||||||
| 12/27/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Gastroenterology | ||||||
| 12/21/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $87.55 | General |
| Category: General - Pain Management_NMD | ||||||
| 12/06/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Gastroenterology | ||||||
| 12/06/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Gastroenterology | ||||||
| 10/17/2023 | Boston Scientific Corporation | CoverEdge 32 (Device) | Food and Beverage | In-kind items and services | $196.28 | General |
| Category: CoverEdge_NMD | ||||||
| 09/27/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Gastroenterology | ||||||
| 09/20/2023 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $69.97 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 08/21/2023 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 07/17/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $6.64 | General |
| Category: General - Pain Management_NMD | ||||||
| 04/26/2023 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 04/26/2023 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 04/03/2023 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $30.02 | General |
| 03/23/2023 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $10.57 | General |
| Category: WaveWriter Alpha_NMD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 2,239 | 11,712 | $2.8M | $402,790 |
| 2022 | 21 | 2,546 | 12,766 | $2.9M | $440,830 |
| 2021 | 25 | 2,567 | 14,799 | $3.2M | $519,740 |
| 2020 | 25 | 2,087 | 11,225 | $2.5M | $394,507 |
All Medicare Procedures & Services
113 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 322 | 581 | $1.1M | $137,513 | 13.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 401 | 620 | $185,276 | $54,744 | 29.5% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 65 | 121 | $145,570 | $41,334 | 28.4% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 64 | 119 | $63,860 | $22,672 | 35.5% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 87 | 130 | $269,533 | $20,652 | 7.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 158 | 158 | $78,462 | $19,402 | 24.7% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 51 | 92 | $135,872 | $18,136 | 13.3% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 109 | 184 | $147,016 | $16,131 | 11.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 170 | 199 | $39,845 | $13,459 | 33.8% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 49 | 89 | $129,789 | $9,170 | 7.1% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 18 | 26 | $31,208 | $8,593 | 27.5% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 16 | 44 | $36,608 | $6,405 | 17.5% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 22 | 34 | $27,166 | $6,386 | 23.5% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 46 | 58 | $97,294 | $6,095 | 6.3% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 18 | 28 | $15,180 | $5,673 | 37.4% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 16 | 44 | $33,660 | $3,307 | 9.8% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 14 | 15 | $11,985 | $2,779 | 23.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 32 | 32 | $11,712 | $2,756 | 23.5% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 12 | 41 | $25,912 | $1,916 | 7.4% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 17 | 33 | $20,856 | $1,304 | 6.3% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 14 | 16 | $39,214 | $1,129 | 2.9% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 18 | 23 | $16,676 | $935.54 | 5.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 390 | 8,886 | $222,150 | $863.16 | 0.4% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 56 | 60 | $4,500 | $741.00 | 16.5% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 61 | 63 | $1,512 | $597.48 | 39.5% |
About Dr. Stephen Long, MD
Dr. Stephen Long, MD is a Specialist healthcare provider based in Richmond, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285613257.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Long, MD has received a total of $3,843 in payments from pharmaceutical and medical device companies, with $902.69 received in 2024. These payments were reported across 113 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($3,359).
As a Medicare-enrolled provider, Long has provided services to 9,439 Medicare beneficiaries, totaling 50,502 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 113 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Richmond, VA
- Active Since 01/10/2006
- Last Updated 10/29/2015
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1285613257
Products in Payments
- WaveWriter Alpha Prime 16 (Device) $606.43
- Exparel (Drug) $483.87
- GENERAL PAIN MANAGEMENT (Device) $468.55
- GENERAL - PAIN MANAGEMENT (Device) $240.59
- General - Pain Management (Device) $204.22
- CoverEdge 32 (Device) $196.28
- Iovera (Device) $177.99
- GENERAL PAIN MANAGEMENT (Device) $140.85
- iFuse Implant (Device) $121.37
- INFINION LEAD PERM (Device) $104.57
- RESTORE (Device) $88.01
- Zipsor (Drug) $80.35
- RELISTOR (Drug) $71.96
- Nalocet (Drug) $71.03
- LYRICA (Drug) $65.81
- Levorphanol (Drug) $52.79
- WAVEWRITER ALPHA (Device) $52.03
- GENERAL THERAPIES (Device) $50.29
- Gralise (Drug) $47.05
- QUTENZA (Drug) $42.84
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Richmond
Dr. Jed Vanichkachorn, Md, MD
Specialist — Payments: $2.0M
Dominick Pastore, M.d, M.D
Specialist — Payments: $628,168
Dr. Hans Tuten, Md, MD
Specialist — Payments: $263,236
Dr. Paul Caldwell, Md, MD
Specialist — Payments: $146,633
Dr. Matthew Dobzyniak, Md, MD
Specialist — Payments: $110,602
Dr. Michael Manetas, M.d, M.D
Specialist — Payments: $91,854